Journal Home
Contents
Editorial Board
Instructions for Contributors
Subscription Rates
© Neva Press, Inc. 2005 |
|
CNS Drug ReviewsTable
of Contents
Volume 1, No. 2
| 129 |
|
The Pharmacology
of GYKI-46 903, a New Cognition Enhancer
Beáta Vitális, Anna Bakonyi, Viola Csillik-Perczel, Edit Horváth, Katalin Horváth,
Ildikó Máté, József I. Székely, Tilahun Yemane, Gizella Ábrahám, Sándor Sólyom
and László G. Hársing, Jr. |
| 149 |
|
Lifarizine: A
Blocker of Inactivated Voltage-dependent Sodium Channels and Calcium Channels with
Cerebral Neuroprotective Action
C. M. Brown, W. R. Rush and H. A. Colquhoun |
| 168 |
|
Imidazenil: A
Potent Benzodiazepine Partial Positive Modulator of GABAergic Transmission Virtually
Devoid of Tolerance Liability
Erminio Costa, D. M. Thompson, J. Auta and A. Guidotti |
| 190 |
|
Lamotrigine
John A. Messenheimer |
| 204 |
|
Lomerizine
(KB-2696), a New Antimigraine Drug
Hideaki Hara, Tominori Morita, Takayuki Sukamoto and F. Michael Cutrer |
| 227 |
|
Glycine Site
Agonists of the NMDA Receptor: A Review
Deepak Cyril D'Souza, Dennis Charney and John Krystal |
| 261 |
|
4-Aminopyridine:
Use in Multiple Sclerosis
Christopher T. Bever, Jr. |
| 280 |
|
SUBJECT
INDEX for Volume 1 |
| 282 |
|
AUTHOR
INDEX for Volume 1 |
|
|
|